Related Experiment Video
Updated: Apr 19, 2026
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Calcific uremic arteriolopathy: a call for action
Vincent M Brandenburg1, Mario Cozzolino2, Sandro Mazzaferro3
1Department of Cardiology and Center for Rare Diseases (Zentrum für seltene Erkrankungen Aachen, ZSEA), RWTH University Hospital, Aachen, Germany.
Insights
Calciphylaxis, a severe skin condition in kidney disease patients, requires urgent research. Understanding its causes and treatments is crucial for improving patient outcomes.
Area of Science:
- Nephrology
- Dermatology
- Cardiology
Background:
- Calciphylaxis, or calcific uremic arteriolopathy (CUA), is a serious condition affecting patients with advanced or end-stage renal disease.
- Diagnosis often occurs in nephrology units, presenting with painful skin lesions that can lead to severe ulcerations and high mortality.
- Current understanding of CUA development and effective therapeutic strategies remains limited.
Purpose of the Study:
- To address the stagnancy in CUA research and therapy.
- To highlight CUA as a critical research target for the CKD-MBD working group.
Main Methods:
- The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) scientific working group CKD-MBD initiated a call to action.
- Defining calciphylaxis as a key research priority.
Main Results:
- Calciphylaxis is recognized as a challenging, multi-disciplinary condition.
- There is a recognized need for advancements in understanding CUA pathogenesis and treatment.
Conclusions:
- Calciphylaxis represents a significant unmet need in nephrology, dermatology, and cardiology.
- Further research into CUA is essential to improve patient morbidity and mortality.
Abstract:
Calciphylaxis (calcific uremic arteriolopathy [CUA]) is a threatening disease that increasingly is acknowledged as a challenging condition at the interface of nephrology, dermatology, and cardiology. The primary CUA diagnosis is determined most often in nephrology care units because the vast majority of affected cases are detected in patients with advanced or end-stage renal disease. The typical clinical cascade starts with severe pain in initially often inconspicuous skin areas, which might progress to deep tissue ulcerations. Ulcer development is a severe complication with particularly high morbidity and mortality. Unfortunately, there has been a certain stagnancy regarding the slow progress in our understanding of how and why CUA develops. In addition, several important open issues regarding therapy have not been addressed successfully yet. Therefore, the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) scientific working group Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) has accepted the challenge and has initiated a call for action by defining calciphylaxis as one of the outstanding research targets for the upcoming years.
Related Concept Videos
01:30Peripheral Artery Disease I: Introduction
01:24Chronic Kidney Disease II: Clinical Manifestations
01:28Diabetic Nephropathy
01:25Chronic Kidney Disease I: Introduction
01:10Nephrons
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...